SARS-CoV2 – Page 117 – Communicable Diseases Research

SARS-CoV-2 COVID-19 susceptibility and lung inflammatory storm by smoking and vaping

Review

Published on 2020-06-102022-10-29
Journal: Journal of Inflammation (London, England) [Category] COVID-19,

Detection of SARS-CoV-2 by bronchoscopy after negative nasopharyngeal testing: Stay vigilant for COVID-19

Case report

Published on 2020-06-092022-10-05
Journal: Respiratory Medicine Case Reports [Category] 치료기술,

[키워드] absence acute respiratory syndrome age aspiration pneumonia BALF Bronchoalveolar lavage fluid center Clinical features clinical suspicion clinical testing clinically Community coronavirus coronavirus disease COVID-19 detection determine Diagnosis epidemiological gold standard healthcare Hospitalization Immunosuppressed implication Infection Injury involved Lower respiratory tract lung nasopharyngeal neurologic occur occurred Older Patient polymerase chain positive positive RT-PCR prevalence of COVID-19 proportion remained required respiratory symptom Result RT-PCR SARS-CoV-2 SARS-CoV2 specimen Spread tested University of Washington upper respiratory tract
[DOI] 10.1016/j.rmcr.2020.101120 [Article Type] Case report

Acute cholecystitis during COVID-19 pandemic: a multisocietary position statement

Commentary

Published on 2020-06-082022-10-29
Journal: World Journal of Emergency Surgery : WJES [Category] COVID-19, SARS,

COVID-19 and Congenital Heart Disease: Results from a Nationwide Survey

Article

Published on 2020-06-082022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

[키워드] acute respiratory syndrome affected cardiovascular cardiovascular complication cardiovascular complications Cardiovascular symptom CHD chest pain children Clinical characteristics Clinical course clinically suspected co-morbidities co-morbidity Cohort Comorbidity Complication complications conducted congenital congenital heart disease contrary coronavirus COVID-19 COVID-19 diagnosis COVID-19 group death defined diabete disease heart heart failure high-risk population hospitalized patients hypertension Italian mechanisms Mild mortality risk myocardial injury novel obesity outcome pandemic Patient patients performed positive pulmonary hypertension recorded Result SARS-CoV2 severe symptom survey
[DOI] 10.3390/jcm9061774 PMC 바로가기 [Article Type] Article

Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era

Observational Study

Published on 2020-06-072023-06-19
Journal: European heart journal [Category] Fulltext, SARS,

[키워드] Acute myocardial infarction Cardiac care units COVID-19 SARS-CoV2 STEMI
[DOI] 10.1093/eurheartj/ehaa409 PMC 바로가기 [Article Type] Observational Study

The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe?

Immunology

Published on 2020-06-052022-11-01
Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS,

[키워드] ACE-2 ACE2 acute respiratory distress syndrome adverse effect affected Ang II angiotensin angiotensin-converting enzyme 2 Antiviral binding Cell COVID-19 Defense dendritic cells Effects expressed expressing expression feature fibrosis Friend glycoprotein high mortality rate homing host cells Hypothesis immune system individual Inflammation lung Macrophage macrophages mechanisms organ organ injury organ-specific other organs other tissue protease pulmonary parenchyma receptor renal Replication reservoir respiratory responsible SARS-CoV SARS-CoV-2 SARS-COV-2 infection SARS-CoV2 severity subsequent tissue Vascular viral spike viral spread
[DOI] 10.3389/fimmu.2020.01312 PMC 바로가기 [Article Type] Immunology

Erhöhtes Risiko für tiefe Beinvenenthrombosen bei Intensivpatienten mit CoViD-19-Infektion? – Erste Daten

Originalien

Published on 2020-06-052022-10-31
Journal: Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen [Category] Coronavirus, SARS,

[키워드] Corona infection Corona-Infektion COVID-19 CoViD-19 associated complications CoViD-19-assoziierte Komplikationen Deep vein thrombosis material Rate SARS-CoV2 Thrombose thrombosis Tiefe Beinvenenthrombose Universitätsklinikum
[DOI] 10.1007/s00104-020-01222-7 PMC 바로가기 [Article Type] Originalien

COVID-19 Presenting With Thalamic Hemorrhage Unmasking Moyamoya Angiopathy

Letter to the Editor

Published on 2020-06-042022-10-31
Journal: The Canadian Journal of Neurological Sciences. Le [Category] Coronavirus, SARS,

[키워드] angiopathy COVID-19 Moyamoya angiopathy SARS-CoV2 Thalamus
[DOI] 10.1017/cjn.2020.117 PMC 바로가기 [Article Type] Letter to the Editor

SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020

Rapid Communication

Published on 2020-06-042022-10-31
Journal: Eurosurveillance [Category] COVID-19, SARS,

A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial

Letter

Published on 2020-06-032022-10-29
Journal: Trials [Category] Coronavirus, SARS,

[키워드] 1:1 48 hour Admission allergic reaction anticipated application AST/ALT Bacterial infection Bacterial infections blinded block Breast feeding clinical clinical trial Combination concealed conducted Contraception Control COVID-19 COVID-19 patient criteria defined dependent on Desirable diagnostic Diaphragm dissemination dose double blind ECMO Efficacy Efficacy and safety element Endpoint evaluate extracorporeal membrane oxygenation failure female Germany Hospital stay Hydroxychloroquine IL-6-Rezeptor blockade Immunosuppression immunosuppressive therapy IMV independent Inflammation ingredient Injury Inpatient intensive care units interfere Invasive mechanical ventilation investigator investigators less life lung failure mechanical ventilation methotrexate NaCl NIV non-invasive ventilation number objective outcome parallel group parameters participant Participation Pathogenesis Patient patients PCT performed placebo-controlled trial Pneumonia polymerase chain positive Prednisolone produced progression proof protocol Pulmonary function pulmonary inflammation Quality of life randomisation randomised randomised controlled trial recruited reduce Registered respiratory Safe Sample size SARS-CoV-2 SARS-CoV2 SARS-CoV2 infection SAS severe COVID-19 Severe COVID-19 pneumonia Simultaneous single dose status stratified Study protocol sulfasalazine System the patient therapy Tocilizumab Treatment Trial trials Tuberculosis ULN unit Ventilation ventilator ventilator free day ventilator free days VFD Viral hepatitis website
[DOI] 10.1186/s13063-020-04447-3 PMC 바로가기 [Article Type] Letter